Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
Caplin, Martyn E, Pavel, Marianne, Ćwikła, Jarosław B, Phan, Alexandria T, Raderer, Markus, Sedláčková, Eva, Cadiot, Guillaume, Wolin, Edward M, Capdevila, Jaume, Wall, Lucy, Rindi, Guido, Langley, Alison, Martinez, Séverine, Blumberg, Joëlle, Ruszniewski, Philippe
Published in The New England journal of medicine (17.07.2014)
Published in The New England journal of medicine (17.07.2014)
Get full text
Journal Article
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
Pavel, Marianne E, Prof, Hainsworth, John D, Prof, Baudin, Eric, MD, Peeters, Marc, Prof, Hörsch, Dieter, Prof, Winkler, Robert E, MD, Klimovsky, Judith, MD, Lebwohl, David, MD, Jehl, Valentine, MSc, Wolin, Edward M, MD, Öberg, Kjell, Prof, Van Cutsem, Eric, Prof, Yao, James C, Dr
Published in The Lancet (British edition) (10.12.2011)
Published in The Lancet (British edition) (10.12.2011)
Get full text
Journal Article
Lanreotide Depot: An Antineoplastic Treatment of Carcinoid or Neuroendocrine Tumors
Wolin, Edward M., Manon, Amandine, Chassaing, Christophe, Lewis, Andy, Bertocchi, Laurent, Richard, Joel, Phan, Alexandria T.
Published in Journal of gastrointestinal cancer (01.12.2016)
Published in Journal of gastrointestinal cancer (01.12.2016)
Get full text
Journal Article
Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors
Strosberg, Jonathan R, Fisher, George A, Benson, Al B, Anthony, Lowell B, Arslan, Bulent, Gibbs, John F, Greeno, Edward, Iyer, Renuka V, Kim, Michelle K, Maples, William J, Philip, Philip A, Wolin, Edward M, Cherepanov, Dasha, Broder, Michael S
Published in World journal of gastroenterology : WJG (28.02.2015)
Published in World journal of gastroenterology : WJG (28.02.2015)
Get full text
Journal Article
Impact of 68Ga-DOTATATE PET/CT on the management of neuroendocrine tumors: the referring physician's perspective
Herrmann, Ken, Czernin, Johannes, Wolin, Edward M, Gupta, Pawan, Barrio, Martin, Gutierrez, Antonio, Schiepers, Christiaan, Mosessian, Sherly, Phelps, Michael E, Allen-Auerbach, Martin S
Published in The Journal of nuclear medicine (1978) (01.01.2015)
Published in The Journal of nuclear medicine (1978) (01.01.2015)
Get full text
Journal Article
Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518
Yao, James C, Guthrie, Katherine A, Moran, Cesar, Strosberg, Jonathan R, Kulke, Matthew H, Chan, Jennifer A, LoConte, Noelle, McWilliams, Robert R, Wolin, Edward M, Mattar, Bassam, McDonough, Shannon, Chen, Helen, Blanke, Charles D, Hochster, Howard S
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
Yao, James C, Shah, Manisha H, Ito, Tetsuhide, Bohas, Catherine Lombard, Wolin, Edward M, Van Cutsem, Eric, Hobday, Timothy J, Okusaka, Takuji, Capdevila, Jaume, de Vries, Elisabeth G.E, Tomassetti, Paola, Pavel, Marianne E, Hoosen, Sakina, Haas, Tomas, Lincy, Jeremie, Lebwohl, David, Öberg, Kjell
Published in The New England journal of medicine (10.02.2011)
Published in The New England journal of medicine (10.02.2011)
Get full text
Journal Article
EVALUATION OF LANREOTIDE DEPOT/AUTOGEL EFFICACY AND SAFETY AS A CARCINOID SYNDROME TREATMENT (ELECT): A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Vinik, Aaron I, Wolin, Edward M, Liyanage, Nilani, Gomez-Panzani, Edda, Fisher, George A
Published in Endocrine practice (01.09.2016)
Published in Endocrine practice (01.09.2016)
Get full text
Journal Article
Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study
Caplin, Martyn E, Pavel, Marianne, Ćwikła, Jarosław B, Phan, Alexandria T, Raderer, Markus, Sedláčková, Eva, Cadiot, Guillaume, Wolin, Edward M, Capdevila, Jaume, Wall, Lucy, Rindi, Guido, Langley, Alison, Martinez, Séverine, Gomez-Panzani, Edda, Ruszniewski, Philippe
Published in Endocrine-related cancer (01.03.2016)
Published in Endocrine-related cancer (01.03.2016)
Get full text
Journal Article
Multifocality in Small Bowel Neuroendocrine Tumors
Gangi, Alexandra, Siegel, Emily, Barmparas, Galinos, Lo, Simon, Jamil, Laith H., Hendifar, Andrew, Nissen, Nicholas N., Wolin, Edward M., Amersi, Farin
Published in Journal of gastrointestinal surgery (01.02.2018)
Published in Journal of gastrointestinal surgery (01.02.2018)
Get full text
Journal Article
Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study
Caplin, Martyn E., Pavel, Marianne, Phan, Alexandria T., Ćwikła, Jarosław B., Sedláčková, Eva, Thanh, Xuan-Mai Truong, Wolin, Edward M., Ruszniewski, Philippe
Published in Endocrine (01.02.2021)
Published in Endocrine (01.02.2021)
Get full text
Journal Article
Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors: analysis of the phase 3, randomized, placebo-controlled RADIANT-2 study
Fazio, Nicola, Granberg, Dan, Grossman, Ashley, Saletan, Stephen, Klimovsky, Judith, Panneerselvam, Ashok, Wolin, Edward M
Published in Chest (01.04.2013)
Published in Chest (01.04.2013)
Get more information
Journal Article
Patient-Reported Experience of Diagnosis, Management, and Burden of Neuroendocrine Tumors: Results From a Large Patient Survey in the United States
Wolin, Edward M, Leyden, John, Goldstein, Grace, Kolarova, Teodora, Hollander, Ron, Warner, Richard R P
Published in Pancreas (01.05.2017)
Published in Pancreas (01.05.2017)
Get more information
Journal Article
Real-world approaches for extending progression-free survival in patients with metastatic pancreatic neuroendocrine tumors: focus on timing, sequencing, regimen initiation, and maintenance strategies using somatostatin analogs, targeted agents, and peptide receptor radiotherapy
Get full text
Journal Article